Step 1: Understanding the Question:
The question asks for a true physiological consequence of using Hydrochlorothiazide (HCTZ) in a patient with a history of kidney stones.
Step 2: Detailed Explanation:
Mechanism of HCTZ: Thiazides act on the distal convoluted tubule. One of their major therapeutic benefits for patients with calcium stones is that they decrease urinary calcium excretion. They do this by enhancing calcium reabsorption in the distal tubule (Option B is also a fact).
Impact on Citrate: Citrate is a natural inhibitor of stone formation in the urine. Thiazides often cause hypokalemia. Hypokalemia induces an intracellular acidosis in the proximal tubule cells of the kidney.
Citrate Handling: This intracellular acidosis stimulates the reabsorption of citrate from the tubular fluid back into the blood, leading to decreased urinary citrate excretion. This is a potential drawback (a pro-lithogenic effect) of thiazide therapy.
Conclusion: While HCTZ is \textit{chosen} because it decreases calcium (Option B), the statement about decreased citrate (Option D) is a physiologically accurate description of its impact on urinary composition, and as per the provided answer key, it is the intended correct statement.
Step 3: Final Answer:
A significant effect of hydrochlorothiazide on the urinary environment is the reduction of citrate excretion, which is a known consequence of thiazide-induced hypokalemia.